Literature DB >> 9585383

Cytopathological findings from fine-needle aspiration biopsy are accurate predictors of thyroid pathology in patients with functioning thyroid nodules.

F Zelmanovitz1, J L Gross.   

Abstract

The cytopathological findings after fine-needle aspiration biopsy (FNAB) of functioning solitary thyroid nodules (FSTN) are not well defined. This is an important issue, once this procedure is the first step in nodule evaluation. This study evaluated FNAB findings and correlated these findings with histopathology in patients subjected to thyroidectomy. Eleven clinically euthyroid female patients (age range: 19 to 47 years) with FSTN, satisfactory specimens from FNAB and negative antithyroid antibodies were studied. Seven patients had autonomous nodules. The cytopathological findings were of follicular pattern suggestive of neoplasia in one case where the histopathological examination confirmed a follicular adenoma. In all other 6 autonomous cases, the smears were suggestive of colloid goiter and they had surgery due to compressive symptoms (n=4) or subclinical hyperthyroidism (n=2). The histopathological results confirmed colloid goiter in all except one who presented a follicular adenoma. Four patients had functioning thyroid nodules that suppressed their 1311 uptake after receiving T3. The cytopathological findings were considered malignant in one case surgically confirmed to be a papillary carcinoma. In all other 3 non-autonomous cases, the smears were suggestive of colloid goiter and they had surgery due to compressive symptoms (n=1), aesthetic reasons (n=11) or increase in nodule volume (n=1). The histopathological results confirmed colloid goiter. In conclusion, FNAB was an accurate predictor of thyroid pathology in FSTN without false-positive results in the present study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585383     DOI: 10.1007/BF03350322

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Fine needle aspiration of the hot thyroid nodule.

Authors:  Y Liel; H J Zirkin; R J Sobel
Journal:  Acta Cytol       Date:  1988 Nov-Dec       Impact factor: 2.319

2.  306 cases of toxic adenoma: clinical aspects, findings in radioiodine diagnostics, radiochromatography and histology; results of 131-I and surgical treatment.

Authors:  W Horst; H Rösler; C Schneider; A Labhart
Journal:  J Nucl Med       Date:  1967-07       Impact factor: 10.057

3.  Hashimoto's thyroiditis simulating cancer of the thyroid.

Authors:  J Wortsman; J Dietrich; J Apesos; J R Folse
Journal:  Arch Surg       Date:  1981-04

4.  Solitary autonomously functioning thyroid nodules and iodine deficiency.

Authors:  A Belfiore; L Sava; F Runello; L Tomaselli; R Vigneri
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

5.  T3 hyperthyroidism and thyroid cancer.

Authors:  R H Kruter; M Liedtke; J A De Castro; J L Gross
Journal:  Clin Endocrinol (Oxf)       Date:  1982-02       Impact factor: 3.478

6.  Management implications from routine needle biopsy of hyperfunctioning thyroid nodules.

Authors:  P G Walfish; H T Strawbridge; I B Rosen
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

7.  The triiodothyronine suppression test.

Authors:  G Burke
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

8.  Clinical examination is not an accurate method of defining the presence of goitre in schoolchildren.

Authors:  H R Lisböa; J L Gross; A Orsolin; S Fuchs
Journal:  Clin Endocrinol (Oxf)       Date:  1996-10       Impact factor: 3.478

9.  Thyroid hormone-producing metastases in differentiated thyroid cancer.

Authors:  J L Gross; I Vasques Moraes
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

10.  Accumulation of iodine-131 and technetium-99m pertechnetate in thyroid carcinoma.

Authors:  M Katagiri; S Suzuki; S Sadahiro; K Kubouchi; T Ohmura; O Tsumura; S Akatsuka
Journal:  Clin Nucl Med       Date:  1988-04       Impact factor: 7.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.